MSN Labs rolls out cheapest Covid-19 drug

Hyderabad: Generic pharmaceuticals maker MSN Group on Thursday announced the launch of India’s cheapest Covid-19 treatment drug Favipiravir 200 mg at Rs 33 per tablet under the Favilow brand. The city-based company also said it is gearing up to roll out Favipiravir 400 mg soon.
The launch of MSN’s Favilow comes a little over a fortnight after Jenburkt Pharmaceuticals launched then India’s cheapest Favipiravir 200 mg, offering Favivent at Rs 39 per tablet.
Cipla too has rolled out its Favipiravir under the Ciplenza brand at Rs 68, while Hyderabad-based Hetero Labs’ Favivir and Brinton Pharma’s Faviton are priced at Rs 59. TNN